Milestone Pharmaceuticals Inc. announced it will release its third quarter 2026 financial results on November 13, 2026, before the market opens. The company, which develops cardiovascular medicines including the FDA-approved nasal spray CARDAMYST® for heart rhythm issues, will hold a conference call and webcast for investors at 8:30 am ET on the same day. This update is important for investors tracking the progress of Milestone's innovative heart treatments and ongoing clinical developments. A replay of the call will be available on the company's website.
Milestone Pharmaceuticals' upcoming Q3 2026 financial results provide context for readers interested in health-sector stocks. As of November 3, 2026, 75 out of 150 health-sector US stocks on Pluang rose while 69 fell. Notable movers include AHCO at USD 6.49 with a 9.81% increase and 90% buy order activity, RVTY at USD 165.00 up 8.80%, and NBIX at USD 155.03 down 6.66%, with the data timestamped at 20:11 WIB.
Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...
Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...
Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...
Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...
Stella-Jones Inc. announced a conference call for November 4, 2026, at 10:00 AM EST to discuss its third quarter 2026 financial results. The call is open to investors, analysts, and interested parties and will be webcast live with a recording availab...
